- Lobbying
- Lobbying by Nephron Pharmaceutical Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Theodore Bornstein | COS Rep. Aspin; COS Sen. Kohl; OSD-DOD |
Philip Kiko | HseJudiciary/ScienceCmte/RpSensenbrenner/CAO |
Phillip Kiko | HseJudiciary/ScienceCmte/RpSensenbrenner/CAO |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Registration
Issue(s) they said they’d lobby about: Reverse payments settlements by generic drug companies and pharmaceutical drug companies.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate